The Study of Technology and the Production of Lyophilized Vaccine against Swine Erysipelas
Abstract
Swine erysipelas is a bacterial disease of world-wide importance. Immunization is very effective in preventing this infection. Vaccines have already been used for 50 years and are safe, efficient and easy to produce. Both inactivated and attenuated vaccines are available to prevent development of clinical signs of swine erysipelas. However, live attenuated vaccines cannot be used in any epizootic situation. For a long time in Albania it has produced an attenuated live vaccine against Erysipelothrix rhusiopathiae. For a long time in Albania it has produced an attenuated live vaccine against Erysipelothrix rhusiopathiae. This vaccine had a limited validity and occasionally gave the post vaccination incidents. To improve the parameters of this vaccine, and to extend its period of validity of we thought to produce a inactivated oily and lyophilized vaccine against Erysipelothrix husiopathiae. This constitutes the purpose of this study.
Keywords: vaccine, lyophilised, swine, Erysipelothrix.
Downloads
Published
How to Cite
Issue
Section
License
Declaration/Copyright transfer:
1. In consideration of the undertaking set out in paragraph 2, and upon acceptance by ANGLISTICUM for publication of the manuscript in the Journal, I/We hereby assign and transfer publication rights to ANGLISTICUM, whereas I/We retain the copyright for the manuscript. This assignment provides ANGLISTICUM the sole right and responsibility to publish the manuscript in its printed and online version, and/or in other media formats.
2. In consideration of this assignment, ANGLISTICUM hereby undertakes to prepare and publish the manuscript in the Journal, subject only to its right to refuse publication if there is a breach of the Author’s warranty in paragraph 4 or if there are other reasonable grounds.
3. Editors and the editorial board of ANGLISTICUM are empowered to make such editorial changes as may be necessary to make the Manuscript suitable for publication.
4. I/We hereby acknowledge that: (a) The manuscript submitted is an original work and that I/We participated in the work substantively and thus I/We hereby are prepared to take public responsibility for the work; (b) I/We hereby have seen and approved the manuscript as submitted and that the manuscript has not either been published, submitted or considered for publication elsewhere; (c) The text, illustration, and any other materials included in the manuscript do not infringe upon any existing copyright or other rights of anyone.
5. I/We hereby indemnify ANGLISTICUM and the respective Editors of the Journal as mentioned in paragraph 3, and hold them harmless from any loss, expense or damage occasioned by a claim or suit by a third party for copyright infringement, or any suit arising out of any breach of the foregoing warranties as a result of publication of the manuscript.
